La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

CHAPTER 13 - Protein Quantification by MRM for Biomarker Validation

Identifieur interne : 000B78 ( Main/Exploration ); précédent : 000B77; suivant : 000B79

CHAPTER 13 - Protein Quantification by MRM for Biomarker Validation

Auteurs : L. Staunton [Irlande (pays)] ; T. Clancy [Norvège] ; C. Tonry [Irlande (pays)] ; B. Hernández [Irlande (pays)] ; S. Ademowo [Irlande (pays)] ; M. Dharsee [Canada] ; K. Evans [Canada] ; A. C. Parnell [Irlande (pays)] ; R. W. Watson [Irlande (pays)] ; K. A. Tasken [Norvège] ; S. R. Pennington [Irlande (pays)]

Source :

RBID : ISTEX:2B32CF5D98B5F441CF7E683D840FB59855D1644A

Abstract

In this chapter we describe how mass spectrometry-based quantitative protein measurements by multiple reaction monitoring (MRM) have opened up the opportunity for the assembly of large panels of candidate protein biomarkers that can be simultaneously validated in large clinical cohorts to identify diagnostic protein biomarker signatures. We outline a workflow in which candidate protein biomarker panels are initially assembled from multiple diverse sources of discovery data, including proteomics and transcriptomics experiments, as well as from candidates found in the literature. Subsequently, the individual candidates in these large panels may be prioritised by application of a range of bioinformatics tools to generate a refined panel for which MRM assays may be developed. We describe a process for MRM assay design and implementation, and illustrate how the data generated from these multiplexed MRM measurements of prioritised candidates may be subjected to a range of statistical tools to create robust biomarker signatures for further clinical validation in large patient sample cohorts. Through this overall approach MRM has the potential to not only support individual biomarker validation but also facilitate the development of clinically useful protein biomarker signatures.

Url:
DOI: 10.1039/9781782626985-00277


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>CHAPTER 13 - Protein Quantification by MRM for Biomarker Validation</title>
<author>
<name sortKey="Staunton, L" sort="Staunton, L" uniqKey="Staunton L" first="L." last="Staunton">L. Staunton</name>
</author>
<author>
<name sortKey="Clancy, T" sort="Clancy, T" uniqKey="Clancy T" first="T." last="Clancy">T. Clancy</name>
</author>
<author>
<name sortKey="Tonry, C" sort="Tonry, C" uniqKey="Tonry C" first="C." last="Tonry">C. Tonry</name>
</author>
<author>
<name sortKey="Hernandez, B" sort="Hernandez, B" uniqKey="Hernandez B" first="B." last="Hernández">B. Hernández</name>
</author>
<author>
<name sortKey="Ademowo, S" sort="Ademowo, S" uniqKey="Ademowo S" first="S." last="Ademowo">S. Ademowo</name>
</author>
<author>
<name sortKey="Dharsee, M" sort="Dharsee, M" uniqKey="Dharsee M" first="M." last="Dharsee">M. Dharsee</name>
</author>
<author>
<name sortKey="Evans, K" sort="Evans, K" uniqKey="Evans K" first="K." last="Evans">K. Evans</name>
</author>
<author>
<name sortKey="Parnell, A C" sort="Parnell, A C" uniqKey="Parnell A" first="A. C." last="Parnell">A. C. Parnell</name>
</author>
<author>
<name sortKey="Watson, R W" sort="Watson, R W" uniqKey="Watson R" first="R. W." last="Watson">R. W. Watson</name>
</author>
<author>
<name sortKey="Tasken, K A" sort="Tasken, K A" uniqKey="Tasken K" first="K. A." last="Tasken">K. A. Tasken</name>
</author>
<author>
<name sortKey="Pennington, S R" sort="Pennington, S R" uniqKey="Pennington S" first="S. R." last="Pennington">S. R. Pennington</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2B32CF5D98B5F441CF7E683D840FB59855D1644A</idno>
<date when="2014" year="2014">2014</date>
<idno type="doi">10.1039/9781782626985-00277</idno>
<idno type="url">https://api-v5.istex.fr/document/2B32CF5D98B5F441CF7E683D840FB59855D1644A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A17</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002A17</idno>
<idno type="wicri:Area/Istex/Curation">002A17</idno>
<idno type="wicri:Area/Istex/Checkpoint">000000</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000000</idno>
<idno type="wicri:doubleKey">2045-7545:2014:Staunton L:chapter:protein:quantification</idno>
<idno type="wicri:Area/Main/Merge">000B83</idno>
<idno type="wicri:Area/Main/Curation">000B78</idno>
<idno type="wicri:Area/Main/Exploration">000B78</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">CHAPTER 13 - Protein Quantification by MRM for Biomarker Validation</title>
<author>
<name sortKey="Staunton, L" sort="Staunton, L" uniqKey="Staunton L" first="L." last="Staunton">L. Staunton</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin 4</wicri:regionArea>
<wicri:noRegion>Dublin 4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Clancy, T" sort="Clancy, T" uniqKey="Clancy T" first="T." last="Clancy">T. Clancy</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital</wicri:regionArea>
<wicri:noRegion>Oslo University Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tonry, C" sort="Tonry, C" uniqKey="Tonry C" first="C." last="Tonry">C. Tonry</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin 4</wicri:regionArea>
<wicri:noRegion>Dublin 4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hernandez, B" sort="Hernandez, B" uniqKey="Hernandez B" first="B." last="Hernández">B. Hernández</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin 4</wicri:regionArea>
<wicri:noRegion>Dublin 4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ademowo, S" sort="Ademowo, S" uniqKey="Ademowo S" first="S." last="Ademowo">S. Ademowo</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin 4</wicri:regionArea>
<wicri:noRegion>Dublin 4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dharsee, M" sort="Dharsee, M" uniqKey="Dharsee M" first="M." last="Dharsee">M. Dharsee</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Ontario Cancer Biomarker Network, Toronto, M5A 2K3</wicri:regionArea>
<wicri:noRegion>M5A 2K3</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Evans, K" sort="Evans, K" uniqKey="Evans K" first="K." last="Evans">K. Evans</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Ontario Cancer Biomarker Network, Toronto, M5A 2K3</wicri:regionArea>
<wicri:noRegion>M5A 2K3</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Parnell, A C" sort="Parnell, A C" uniqKey="Parnell A" first="A. C." last="Parnell">A. C. Parnell</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Mathematical Sciences and University College Dublin, Dublin 4</wicri:regionArea>
<wicri:noRegion>Dublin 4</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Irlande (pays)</country>
</affiliation>
</author>
<author>
<name sortKey="Watson, R W" sort="Watson, R W" uniqKey="Watson R" first="R. W." last="Watson">R. W. Watson</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin 4</wicri:regionArea>
<wicri:noRegion>Dublin 4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tasken, K A" sort="Tasken, K A" uniqKey="Tasken K" first="K. A." last="Tasken">K. A. Tasken</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital</wicri:regionArea>
<wicri:noRegion>Oslo University Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pennington, S R" sort="Pennington, S R" uniqKey="Pennington S" first="S. R." last="Pennington">S. R. Pennington</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin 4</wicri:regionArea>
<wicri:noRegion>Dublin 4</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="s">New Developments in Mass Spectrometry</title>
<idno type="ISSN">2045-7545</idno>
<idno type="eISSN">2045-7553</idno>
<idno type="ISSN">2045-7545</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">2045-7545</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">In this chapter we describe how mass spectrometry-based quantitative protein measurements by multiple reaction monitoring (MRM) have opened up the opportunity for the assembly of large panels of candidate protein biomarkers that can be simultaneously validated in large clinical cohorts to identify diagnostic protein biomarker signatures. We outline a workflow in which candidate protein biomarker panels are initially assembled from multiple diverse sources of discovery data, including proteomics and transcriptomics experiments, as well as from candidates found in the literature. Subsequently, the individual candidates in these large panels may be prioritised by application of a range of bioinformatics tools to generate a refined panel for which MRM assays may be developed. We describe a process for MRM assay design and implementation, and illustrate how the data generated from these multiplexed MRM measurements of prioritised candidates may be subjected to a range of statistical tools to create robust biomarker signatures for further clinical validation in large patient sample cohorts. Through this overall approach MRM has the potential to not only support individual biomarker validation but also facilitate the development of clinically useful protein biomarker signatures.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>Irlande (pays)</li>
<li>Norvège</li>
</country>
</list>
<tree>
<country name="Irlande (pays)">
<noRegion>
<name sortKey="Staunton, L" sort="Staunton, L" uniqKey="Staunton L" first="L." last="Staunton">L. Staunton</name>
</noRegion>
<name sortKey="Ademowo, S" sort="Ademowo, S" uniqKey="Ademowo S" first="S." last="Ademowo">S. Ademowo</name>
<name sortKey="Hernandez, B" sort="Hernandez, B" uniqKey="Hernandez B" first="B." last="Hernández">B. Hernández</name>
<name sortKey="Parnell, A C" sort="Parnell, A C" uniqKey="Parnell A" first="A. C." last="Parnell">A. C. Parnell</name>
<name sortKey="Parnell, A C" sort="Parnell, A C" uniqKey="Parnell A" first="A. C." last="Parnell">A. C. Parnell</name>
<name sortKey="Pennington, S R" sort="Pennington, S R" uniqKey="Pennington S" first="S. R." last="Pennington">S. R. Pennington</name>
<name sortKey="Tonry, C" sort="Tonry, C" uniqKey="Tonry C" first="C." last="Tonry">C. Tonry</name>
<name sortKey="Watson, R W" sort="Watson, R W" uniqKey="Watson R" first="R. W." last="Watson">R. W. Watson</name>
</country>
<country name="Norvège">
<noRegion>
<name sortKey="Clancy, T" sort="Clancy, T" uniqKey="Clancy T" first="T." last="Clancy">T. Clancy</name>
</noRegion>
<name sortKey="Tasken, K A" sort="Tasken, K A" uniqKey="Tasken K" first="K. A." last="Tasken">K. A. Tasken</name>
</country>
<country name="Canada">
<noRegion>
<name sortKey="Dharsee, M" sort="Dharsee, M" uniqKey="Dharsee M" first="M." last="Dharsee">M. Dharsee</name>
</noRegion>
<name sortKey="Evans, K" sort="Evans, K" uniqKey="Evans K" first="K." last="Evans">K. Evans</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B78 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B78 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:2B32CF5D98B5F441CF7E683D840FB59855D1644A
   |texte=   CHAPTER 13 - Protein Quantification by MRM for Biomarker Validation
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022